Φόρτωση

Slzii.com Αναζήτηση

Αναζήτηση (Νέα)

Traveloka Launches 7.7 Epic Sale in Vietnam: Flat Prices from 777,000 VND, Up to 50% Off Sitewide, and Buy 1 Get 1 on Hotels and Activities
HO CHI MINH CITY and HANOI, Vietnam , July 6, 2026 /PRNewswire/ -- Traveloka , Southeast Asia's all-in-one travel tech platform, today launched its 7.7 Epic Sale, a region-wide campaign running 6 to 10 July 2026. The annual double-date sale offers travellers discounts across flights, hotels, and activities, with the biggest savings landing on the 7 July peak day. In Vietnam, the sale features flat-price flights from 777,000 VND, up to 50% off sitewide, and Buy 1 Get 1 deals on hotels and activities. Daily flash sales run in two windows — 11 AM to 1 PM and 8 PM to 10 PM — with additional flash sales released on the 7 July peak day. Traveloka is built for Vietnamese travellers, with local payment support and competitive fares on both domestic getaways and regional escapes. Travellers can book flights, hotels, activities, eSIM, and travel insurance, and pay via credit card, VNPay, Momo, convenience stores, bank transfer, and many more, all in one app. "The 7.7 Epic Sale brings travellers across Southeast Asia great-value deals on flights, hotels and activities — all in one app," said Alex Jung, Head of Marketing, Traveloka. Frequently asked questions How can I get the best flight deals in Vietnam during 7.7? Traveloka's 7.7 Epic Sale runs 6–10 July 2026, with flat-price flights from 777,000 VND and up to 50% off sitewide. Daily flash sales run from 11 AM to 1 PM and 8 PM to 10 PM, with an exclusive midnight session from 12 AM to 2 AM on July 7 to mark the peak day of the campaign. To get the most off, book during a flash-sale window and apply an eligible coupon at checkout. Which travel app has the best flight and hotel deals in Vietnam? Traveloka brings flights, hotels and activities together in one app, with access to over 2 million hotels worldwide. During the 7.7 Epic Sale, travellers in Vietnam can find flat-price flights from 777,000 VND, up to 50% off sitewide, and Buy 1 Get 1 deals on hotels and activities.
2026-07-06 07:08:00

Awqaf Ministry organises intensive Quran programme in Madinah for outstanding Qatari students

Doha, Qatar: The Ministry of Awqaf and Islamic Affairs, represented by the Department of Da’wah and Religious Guidance, has launched an intensive Quran programme in Madinah for 30 outstanding Qatari students from Al Noor Educational Quranic Centre and Al Emadi Educational Quranic Centre, as part of its efforts to nurture a generation distinguished by Quranic excellence, sound Islamic values and leadership.

The programme, running from July 2 to 13, 2026, is being held at the Prophet’s Mosque in Madinah and forms part of the ministry’s specialised educational and training initiatives implemented by the Quran and Quranic Sciences Section.

The initiative aims to enhance students’ Quran memorisation, revision and recitation skills while making productive use of the summer break through academic and faith-based activities designed to develop well-rounded Quranic personalities in a spiritually enriching environment.

The 30 participants, selected from among the centres’ top-performing students, are following personalised learning plans tailored to their academic level and educational needs to maximise progress in memorisation, revision and mastery of Quranic recitation.

The ministry said the programme is part of a broader strategy to identify, support and develop talented Qatari students in Quran memorisation by providing advanced educational and character-building opportunities that strengthen both their academic abilities and personal development.

It added that these initiatives seek to deepen young people’s connection with the Holy Quran, instil Quranic values in their daily lives, promote discipline, responsibility and commitment, and prepare them to become positive role models capable of serving their religion, community and country.

The Quran and Quranic Sciences Section also continues to implement a range of specialised initiatives to strengthen the ministry’s Quranic centres and improve their educational outcomes, supporting the preparation of qualified national talent in the fields of imamate, preaching, religious guidance and Islamic education.

Head of the Quran and Quranic Sciences Section and supervisor of the programme, Fahad Ahmed Al Mohannadi, said the course reflects the ministry’s commitment to developing a distinguished Quranic generation whose relationship with the Quran extends beyond memorisation to understanding, reflection and practical application in everyday life.

He noted that the ministry’s educational Quranic centres attract high-achieving Qatari students from Quran memorisation circles and provide specialised programmes that nurture their talents and prepare them to become qualified imams, preachers and Islamic scholars capable of conveying the message of the Quran while serving their religion and nation.

Al Mohannadi added that the ministry remains committed to providing advanced educational opportunities that enable outstanding students to achieve high standards in Quran memorisation and Quranic sciences, qualify them to represent Qatar in regional and international Quran competitions, and equip them with knowledge in Sharia, imamate, preaching and religious guidance.


2026-07-06 07:01:53

Why Morocco-US relations are becoming a strategic alliance
Why Morocco-US relations are becoming a strategic alliance The next chapter of Morocco-US relations will not be written by history alone. It will be shaped by vision, sustained by mutual confidence. Sunday 05/07/2026 The US and Moroccan flags are placed next to each other at the ministry of foreign affairs in Rabat. Diplomatic messages often disappear into the archives, remembered only by protocol specialists. Occasionally, however, a message transcends ceremony and reveals the strategic direction of an alliance. King Mohammed VI’s message to US President Donald Trump on the occasion of America’s 250th Independence anniversary belongs to that rarer category. Its significance lies not merely in its congratulatory tone, but in the political message it conveys: Morocco and the United States are moving beyond a historic friendship and into a strategic alliance. What once rested primarily on goodwill and shared history is now being reinforced by converging interests in security, economics, diplomacy and regional stability. The timing itself is meaningful. As the United States celebrates two and a half centuries of independence, Morocco reminds Washington that theirs is among America’s oldest international friendships. Morocco was the first nation to recognise the independence of the United States, establishing a relationship that predates many of today’s most celebrated alliances. But history here is not being invoked as nostalgia. It is being used as the foundation for a deeper strategic partnership. Yet the message looks decisively toward the future. At its core lies the recognition that bilateral relations have evolved far beyond traditional diplomacy. Security cooperation, military interoperability, economic engagement, investment, intelligence coordination, renewable energy, technological innovation and regional diplomacy now form an increasingly integrated alliance. Perhaps the clearest illustration of this transformation is the annual African Lion exercises. Once viewed primarily as military drills, they have evolved into one of the largest multinational security platforms on the African continent, reflecting a shared understanding that security today encompasses humanitarian assistance, disaster response, counterterrorism, cybersecurity and regional resilience. This is not simply cooperation between friends; it is the operational behavior of strategic allies. Equally important is the political dimension. The king’s reference to President Trump’s recognition of Morocco’s sovereignty over the Sahara underscores that certain diplomatic decisions can reshape strategic landscapes for decades. Regardless of domestic political transitions in Washington, that decision fundamentally altered international perceptions of the dispute, encouraged broader diplomatic momentum in favour of Morocco’s autonomy initiative and reinforced Rabat’s role as a reliable strategic ally in a region where stability has become an increasingly scarce commodity. The message also highlights an often-overlooked reality: contemporary alliances are measured less by declarations than by consistency. For decades, Morocco has demonstrated continuity in its foreign policy, investing patiently in long-term partnerships while maintaining credibility across Africa, Europe, the Arab world and the Atlantic community. In an era marked by geopolitical fragmentation and rapidly shifting alignments, such predictability has become an increasingly valuable strategic asset. It is one reason Morocco is no longer seen only as a historic partner, but as a dependable ally. Economic relations deserve equal attention. Trade and investment have accelerated significantly in recent years, but their real potential remains largely untapped. Morocco’s expanding industrial base, advanced automotive and aerospace sectors, renewable energy ambitions, critical mineral resources and strategic Atlantic location position it as an increasingly attractive platform for American companies seeking resilient supply chains and diversified investment destinations. At a time when global production networks are being reconfigured, Morocco offers something that many emerging markets struggle to provide simultaneously: political stability, institutional continuity, modern infrastructure, preferential access to multiple markets and a clear long-term development vision. These are not the attributes of a symbolic friendship alone; they are the building blocks of a strategic alliance. This convergence extends well beyond economics. Washington increasingly views Africa as a theater of strategic competition, while Morocco has consolidated its role as a gateway to the continent through extensive economic, financial and diplomatic engagement. The intersection of these respective priorities creates opportunities for a partnership that extends beyond bilateral interests toward joint initiatives across Africa in infrastructure, clean energy, digital transformation, education, healthcare and regional security. In other words, Morocco and the United States are not just cooperating; they are aligning strategically. What emerges, therefore, is not merely an anniversary celebration but an affirmation of strategic convergence. In a world increasingly defined by uncertainty, enduring partnerships acquire greater value than ever before. Morocco and the United States possess something few bilateral relationships can claim simultaneously: historical legitimacy, political trust, expanding economic complementarities and converging geopolitical interests. That combination is what turns a long friendship into a strategic alliance. The challenge now is no longer preserving this exceptional relationship. It is deepening it into one of the defining strategic partnerships of the Atlantic century. The next chapter of Morocco-US relations will not be written by history alone. It will be shaped by vision, sustained by mutual confidence and measured by the capacity of both nations to translate an extraordinary legacy into an even more consequential strategic alliance.
2026-07-05 04:56:55

Gulf oil exports jump in June on record UAE flows
Gulf oil exports jump in June on record UAE flows Combined crude and condensate exports from Saudi Arabia, the UAE, Kuwait, Iraq and Iran rose by more than 3.5 million bpd from May to 10.07 million bpd. Sunday 05/07/2026 A worker uses a handheld radio at Iraqi Drilling Company at Zubair oilfield in Basra, Iraq. LONDON Gulf oil exports in June jumped more than 3 million barrels from May to exceed 10 million barrels per day as the US military helped to keep oil flowing through the Strait of Hormuz, data showed, though exports remained 40 percent below pre-war levels. The United Arab Emirates led the recovery, allowing millions of barrels of crude stranded in the Gulf to reach international markets, enabling producers to raise output and lower oil prices to pre-conflict levels. Combined crude and condensate exports from Saudi Arabia, the UAE, Kuwait, Iraq and Iran rose by more than 3.5 million bpd from May to 10.07 million bpd, Kpler data shows. Vortexa, another cargo analytics company, estimated June flows at 10.2 million bpd, up from 7 million bpd in May but still way short of the 16.5 million bpd a year earlier. Since the June 17 agreement between the US and Iran to halt the conflict and restore shipping through the Strait of Hormuz, the backlog of crude stranded in the Gulf cleared more quickly, leaving about 23 million barrels still to transit the waterway, said Kpler analyst Johannes Rauball. Floating storage in the strait had peaked at 96 million barrels in late April, he added. UAE exports reached a record 3.7 million to 3.8 million bpd in June, Kpler, Vortexa and LSEG data showed, more than 1 million bpd above May levels. Ship broker BRS said 98 tankers crossed the strait between June 22 and June 28, about 14 a day and the highest since the conflict began. The traffic included 47 laden outbound tankers and 41 ballast vessels entering the Gulf, indicating ship owners are increasingly willing to send vessels into the region. Saudi crude exports rose by 768,000 bpd to 4.52 million bpd in June, according to Kpler. Exports averaged about 6.3 million bpd last week, close to January levels, as Riyadh boosted loadings from Ras Tanura. During the conflict, Saudi Arabia and the UAE diverted some exports through pipelines bypassing Hormuz, an option largely unavailable to Iraq and Kuwait. ADNOC also used a tanker shuttle service to help to sustain exports. Exports from Iraq and Kuwait recovered to about 800,000 bpd each, Vortexa data showed. Kuwait raised output sharply in June to 1.65 million bpd, a source told Reuters. Iran raised exports by more than 70 percent in June to 640,000 bpd as the US blockade eased, Vortexa said. Suggested By Editor Saudi Aramco ramps up exports from Ras Tanura, switches to spot sales Kuwait sharply boosts crude production in June after US-Iran deal Suggested By Editor Saudi Aramco ramps up exports from Ras Tanura, switches to spot sales Kuwait sharply boosts crude production in June after US-Iran deal
2026-07-05 04:53:47

Egypt expects €1.5 billion from EU assistance package in coming days
Egypt expects €1.5 billion from EU assistance package in coming days The macro-financial assistance forms part of a broader €7.4 billion funding deal the EU announced in 2024, which also includes €5 billion in concessional loans. Sunday 05/07/2026 DUBAI Egypt expects to receive €1.5 billion ($1.72 billion) from the European Union in the coming days, the first of two remaining tranches of a €5 billion macro-financial assistance package, Foreign Minister Badr Abdelatty said on Saturday. Speaking at DUBAI Egypt expects to receive €1.5 billion ($1.72 billion) from the European Union in the coming days, the first of two remaining tranches of a €5 billion macro-financial assistance package, Foreign Minister Badr Abdelatty said on Saturday. Speaking at a news conference in Egypt’s new administrative capital alongside European Commissioner for the Mediterranean Dubravka Suica, Abdelatty said the outstanding €3 billion would be disbursed in two equal tranches of €1.5 billion each. He said Cairo hoped the last payment would be transferred by the start of the autumn. The EU has so far disbursed €2 billion of the package, having transferred an initial €1 billion tranche in January 2025 and a second €1 billion earlier this year. The macro-financial assistance forms part of a broader €7.4 billion funding deal the EU announced in 2024, which also includes €5 billion in concessional loans.
2026-07-05 04:50:08

Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
CAMBRIDGE, Mass. , July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) diseases. This collaboration will leverage Nona Biosciences' proprietary Harbour Mice ® fully human HCAb platform to discover and develop next-generation single-domain antibody-based blood-brain barrier (BBB)-crossing technologies. Leveraging the platform's proven ability to generate fully human HCAbs and VHH binders with exceptional affinity and developability, the partnership aims to establish a best-in-class BBB-crossing technology capable of enabling the delivery of a diverse range of therapeutic modalities into the central nervous system (CNS) and unlocking new opportunities in CNS drug development and technology licensing. As part of the collaboration, Lonza's protein development expertise, world-leading GS Gene Expression System ® and GlycoConnect ® bioconjugation technology will complement Nona's platform by supporting the optimization and broader application of selected BBB-crossing candidates. Under the terms of the agreement, Nona is entitled to receive upfront and option payments from Lonza. The parties will also share revenues generated from future licensing agreements pursuant to the collaboration. Dr. Jingsong Wang, Chairman of Nona Biosciences, commented: "This partnership reflects validates Nona's platform and strategic focus in next-generation delivery technologies. Lonza's global reach, regulatory expertise, and commercial manufacturing capabilities will help accelerate the advancement of our BBB-crossing-technology. Beyond technology development, the collaboration creates opportunities for licensing, commercialization and long-term value creation, while strengthening our position in the CNS delivery space and supporting better outcomes for patients." Dr. Di Hong, Chief Executive Officer of Nona Biosciences, added: "We are excited to partner with Lonza to develop and commercialize best-in-class BBB-crossing technologies for CNS diseases. This collaboration underscores the power and versatility of our HCAb Harbour Mice ® platform and its ability to generate differentiated, fully human single-domain binders that can tackle the most challenging delivery barriers in drug development. By combining our platform with Lonza's services and development and manufacturing expertise, we are confident to offer next-generation BBB-crossing solutions that can unlock new treatment paradigms for patients suffering from devastating CNS disorders." Peter Droc, Head of Licensing, Lonza, commented: "With the acquisition of IP rights to Nona's BBB-crossing technology and through our continued collaboration, we are immediately enabling our customers to translate promising CNS assets into viable therapeutics. By combining this with flexible CDMO services, we allow partners to engage with us at any stage of their journey – from technology licensing to fully integrated development and commercial manufacturing – reducing complexity and helping accelerate the path to patients." About Nona Biosciences Nona Biosciences, a wholly owned subsidiary of HBM Holding Limited (HKEX:02142), is a global biotechnology company committed to advancing biotherapeutic innovation through cutting-edge technology platforms and integrated solutions. Nona supports programs with its I to I ® framework, from early-stage ideas through preclinical research and advancement toward IND and early clinic, spanning target validation and antibody discovery to early development. Nona's proprietary Harbour Mice ® technology platform generates fully human monoclonal antibodies in classical two light and two heavy chain (H2L2) format, and heavy chain-only (HCAb) format. The HCAb Harbour Mice ® is the world's first fully human HCAb transgenic mouse with clinical validation. This unique platform offers exceptional versatility for diverse applications using fully human VH single-domain antibodies as a plug-and-play system, including bispecific antibodies, multi-specific antibodies, CAR-T therapies, antibody-drug conjugates (ADCs), mRNA-based therapeutics, and more. By integrating Harbour Mice ® , single-B cell screening technology, NonaCarFxTM (a direct CAR-function-based screening platform), Hu-mAtrIxTM (an AI-driven drug discovery platform), Modalities-on-Demand ® (a next-generation modalities solution), and end-to-end preclinical drug development services, Nona Biosciences is dedicated to driving the global invention of transformative next-generation drugs. For more information, please visit: www.nonabio.com .
2026-07-02 00:05:00

Segway and Whoosh Launch Free Ride Campaign Across Mexico During the 2026 Tournament World Cup to Support Urban Mobility
BEIJING , June 27, 2026 /PRNewswire/ -- Segway Commercial, a global leader in shared micromobility solutions, has partnered with leading shared mobility operator Whoosh to launch a free ride campaign across Mexico during the 2026 World Cup period. The initiative is designed to help football fans, residents and visitors get around more easily during the tournament, providing convenient transportation between transit hubs, stadiums, fan zones and other key destinations in host cities. Whoosh launched the campaign in Mexico City on June 10 and would expand to Monterrey within the following two weeks, broadening its reach across key urban mobility hubs in Mexico through July 5. Together, Segway and Whoosh would sponsor thousands of rides. Users can redeem one complimentary ride through the operator apps by entering a promotional code: RIDEWITHSEGWAY. Each free ride includes scooter unlocking and up to 20 minutes of riding, subject to daily availability and offered in limited quantities during the campaign period. The campaign reflects the growing role of shared micromobility in addressing urban mobility demand during large-scale international events. Shared mobility networks are increasingly being integrated into event-driven transportation planning, particularly for improving last-mile connectivity during periods of elevated travel demand. Considering the high parking demand and costs during the World Cup period, Free Ride empowers fans with seamless mobility and completely eliminates parking fees, demonstrating micromobility is no longer just an alternative transit option—it is an essential pillar of modern event transportation. "At Whoosh, we believe shared micromobility plays a key role in building more connected, efficient, and sustainable cities. Our partnership with Segway Commercial strengthens this vision by combining reliable technology with operational expertise to bring users in CDMX and Monterrey a practical alternative for short-distance trips, especially during major events such as World Cup games. Through initiatives like free rides, we aim to improve the urban mobility experience and complement the transportation options already available in the city," said Sebastien Declety, Country Manager Whoosh Mexico. "The World Cup presents a unique opportunity to demonstrate how shared micromobility can help cities respond to dynamic transportation needs during major events," said Zack Yan,Vice General Manager of Segway-Ninebot Commercial Mobility Business Division. "Our collaboration with Whoosh reflects a shared commitment to delivering accessible, efficient and sustainable transportation solutions that improve everyday urban mobility experiences." As the tournament reaches its most exciting stages, Segway and Whoosh remain committed to keeping host cities moving—ensuring that whether it's the final match or a daily commute, fans and residents can always ride with ease. Yet, long after the final match concludes, this collaboration leaves a lasting blueprint for delivering accessible and sustainable transit solutions when cities need them most.
2026-06-26 16:03:00

Education Ministry reopens applications for educational vouchers

Doha, Qatar: The Ministry of Education and Higher Education (MOEHE) announced on Thursday, June 25, the reopening of applications for educational vouchers through the "Maarif" public services portal. 

The initiative stems from the Ministry's commitment to providing this opportunity to the largest possible segment of eligible Qatari students, thereby promoting equal educational opportunities through the Ministry's social responsibility project implemented in cooperation with private schools and kindergartens. The project allows eligible students to benefit from diverse educational options in accordance with the approved regulations and requirements.

In a statement, the Ministry explained that it has updated the eligibility criteria, most notably raising the maximum actual family income, after deducting all financial obligations, to QAR 35,000 per month.

In this context, Director of the Private Schools and Kindergartens Department and Acting Director of the Private Schools Licensing Department at MOEHE, Dr. Rania Mohammed affirmed that the ministry's Corporate Social Responsibility (CSR) project, launched in partnership with private schools and kindergartens, continues to expand its support for eligible families. She noted that the project currently provides more than 9,000 seats distributed across four categories: fully free, discounted, seats for students with disabilities, and sreats subsidized by educational vouchers.

She indicated that the project includes approximately 2,400 seats funded by educational vouchers. She explained that these seats allow parents to enroll their children in schools participating in the educational voucher system without incurring any additional tuition fees, even if the school's annual fees exceed the value of the educational voucher, which is QAR 28,000. The school owners cover the difference as part of their contribution to the CSR project.

The Ministry noted that it has introduced a significant update to the eligibility criteria for subsidized educational voucher seats, raising the maximum monthly income limit for families from 25,000 riyals to 35,000 riyals. This increase aims to broaden the number of beneficiaries of this initiative.

Dr. Rania Mohammed emphasized that the term "actual family income" refers not only to the salary stated on the official payslip, but also to the remaining income after deducting all financial obligations. She stressed the importance of parents submitting the original payslip along with supporting documents proving other financial obligations when applying for available seats.

She confirmed that eligible Qatari parents can submit their applications electronically through the "Maarif" portal on the Ministry's website, attaching all required documents to complete the application process and secure a seat.


2026-06-25 14:55:36

Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Racura Oncology has dosed the first patient in the HARNESS-1 Phase 1a/b trial of RC220 in combination with osimertinib for EGFR-mutant non-small cell lung cancer. The study will assess safety, pharmacokinetics, ctDNA dynamics and early clinical activity of RC220 as a strategy to address therapeutic TKI resistance. SYDNEY , June 25, 2026 /PRNewswire/ -- Racura Oncology Limited (ASX: RAC), a clinical-stage biopharmaceutical company developing new small molecule based approaches to cancer treatment, today announced that the first patient has been dosed with RC220 in HARNESS-1, a Phase 1a/b clinical trial evaluating RC220 in combination with osimertinib in patients with epidermal growth factor receptor-mutant (EGFR-mutant) non-small cell lung cancer (NSCLC). The first patient received RC220 at 50 mg/m 2 by intravenous infusion. No adverse events were observed. HARNESS-1 is designed to test whether RC220, Racura's proprietary formulation of (E,E)-bisantrene, can be safely combined with osimertinib (Tagrisso ® ; AstraZeneca), a third-generation EGFR tyrosine kinase inhibitor (TKI) and standard-of-care therapy for EGFR-mutant NSCLC to delay or prevent TKI treatment resistance. Although EGFR TKIs have transformed outcomes for many patients with EGFR-driven lung cancer, acquired treatment resistance remains a central therapeutic challenge. Daniel Tillett, Ph.D., Chief Executive Officer of Racura Oncology, said: "Dosing the first patient in HARNESS-1 is an important milestone for Racura and for the clinical development of RC220. The scientific rationale for this trial is grounded in the urgent need to address TKI therapeutic resistance in EGFR-mutant NSCLC. RC220 gives us the opportunity to explore whether targeting G4-DNA and RNA structures, including MYC-associated growth pathways, can delay EGFR TKI resistance arising and support a new therapeutic combination for patients treated with osimertinib. We are grateful to Associate Professor Surein Arulananda and the Monash Health team for enrolling and treating the first participant, and to the patients and families who make this research possible." Scientific Rationale EGFR-mutant NSCLC is a molecularly stratified lung adenocarcinoma subtype driven by constitutive EGFR kinase signaling and initial sensitivity to EGFR inhibition. However, responses to EGFR tyrosine kinase inhibitors, including osimertinib, are typically limited by acquired resistance, arising through heterogeneous mechanisms such as secondary EGFR alterations, bypass receptor tyrosine kinase activation, MAPK/PI3K pathway reactivation, oncogenic fusions, lineage plasticity, epithelial-to-mesenchymal transition and histologic transformation. RC220 is being developed to target the non-canonical G-quadruplex DNA and RNA structures enriched in oncogenic regulatory regions, including promoters, untranslated regions and highly transcribed loci. Stabilization of these structures can disrupt transcriptional and post-transcriptional control networks that sustain malignant proliferation, including silencing the c-MYC-regulated growth and survival pathways. HARNESS-1 is designed to evaluate the safety and tolerability of RC220 with continued osimertinib-mediated EGFR suppression, while generating pharmacokinetic, pharmacodynamic, molecular response and translational biomarker data. HARNESS-1 Trial Design HARNESS-1 is a multi-center Phase 1a/b clinical study in patients with EGFR-mutant NSCLC receiving osimertinib. The study includes an observational screening stage using ctDNA to help identify eligible patients and characterize tumor molecular status before treatment. The Phase 1a dose-escalation stage will evaluate RC220 administered by intravenous infusion on Day 1 of each 21-day cycle in combination with standard-of-care maintenance osimertinib. The first three dose levels will use single-patient cohorts at 50 mg/m 2 , 100 mg/m 2 and 150 mg/m 2 , before progressing to larger cohorts to identify the maximum tolerated dose and an appropriate dose for further study. Between 12 and 40 patients are expected to participate in the dose-escalation stage. Following review of available safety and pharmacokinetic data, the study is expected to advance into a double-blind, randomized Phase 1b expansion stage. In this dose expansion stage, 40 patients will receive one of two RC220 dose levels in combination with osimertinib. Patients will be monitored for safety, pharmacokinetics and early signals of clinical activity, including progression-free survival, overall survival, ctDNA dynamics and changes in cancer-specific mutations. The first patient was treated by Principal Investigator Associate Professor Surein Arulananda and his team at Monash Health in Clayton, Victoria. Additional clinical trial sites are expected to open in the coming months to support patient recruitment and study progress. Clinical Trial Information Further details about HARNESS-1, including open and recruiting sites, are available through the Australian and New Zealand Clinical Trial Registry at www.anzctr.org.au under trial code ACTRN12626000325303. Clinical trial inquiries may be directed to Racura Oncology at trials@racuraoncology.com . About RC220 & (E,E)-bisantrene RC220 is a proprietary formulation of (E,E)-bisantrene designed to overcome drug solubility issues that prevent safe peripheral intravenous infusion. (E,E)-bisantrene, is a clinical validated small molecule anticancer agent that primarily functions via G4-DNA and RNA binding, leading to potent transcriptional silencing of the important cancer growth regulator c-MYC. About Racura Oncology Racura Oncology (ASX: RAC) is a Phase 3 clinical-stage biopharmaceutical company with a mission to silence cancer. Our lead asset, (E,E)-bisantrene, is a small molecule anticancer agent that primarily functions via G4-DNA and RNA binding, leading to potent silencing of the important cancer growth regulator MYC. Racura is advancing RC220 to address the high unmet needs of patients across multiple oncology indications, including a Phase 3 clinical program in acute myeloid leukemia (AML), a Phase 1 program in mutant epidermal growth factor receptor non-small cell lung cancer (EGFRm NSCLC), and a Phase 1 program in combination with the anthracycline doxorubicin, where we aim to deliver both cardioprotection and enhanced anticancer activity for solid tumor patients. Learn more at www.racuraoncology.com . Forward-Looking Statements Some of the statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this release include, without limitation, statements regarding expectations regarding clinical development and regulatory strategy and the Company's ability to deliver meaningful value to patients and shareholders. These statements relate to future events, future expectations, plans and prospects. Although Racura believes the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Racura has attempted to identify forward-looking statements by terminology including "believes", "estimates", "anticipates", "expects", "plans", "projects", "intends", "potential", "may", "could", "might", "will", "should", "approximately" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including market and other conditions. Any forward-looking statements contained in this press release speak only as of its date. Racura undertakes no obligation to update any forward-looking statements contained in this press release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events, except as required by law.
2026-06-25 14:51:00

Landmines, hunger threaten Syria’s recovery as 13 million face food insecurity
Landmines, hunger threaten Syria’s recovery as 13 million face food insecurity Through its 2026-2028 Emergency and Recovery Plan, the FAO aims to assist 9.8 million people across Syria and is seeking $286 million in funding. Wednesday 24/06/2026 A food vendor prepares corn in Aleppo, Syria. DAMASCUS More than half of Syria’s population is facing acute food insecurity as years of conflict, climate shocks and economic decline continue to devastate the country’s agricultural sector, the UN Food and Agriculture Organization (FAO) has warned. Speaking to journalists in Geneva, Pirro-Tomaso Perri, the FAO’s acting representative in Syria, said the country’s agriculture sector stood at a critical juncture after more than a decade of war, recurrent droughts and mounting economic hardship. “Syria’s agricultural sector is at a pivotal moment after 14 years of conflict, recurrent droughts, economic difficulties, damaged irrigation systems, weakened services, disrupted markets and widespread contamination by explosive remnants of war,” Perri said. He stressed that safe access to farmland had become essential at a time when food conditions remained extremely fragile across the country. According to FAO estimates, around 13.4 million Syrians are experiencing high levels of acute food insecurity, underscoring the scale of the humanitarian challenge facing the country. One of the most significant obstacles to agricultural recovery remains the contamination of farmland and grazing areas with landmines and unexploded ordnance left behind by years of fighting. Perri said that since the end of 2024, 1,299 incidents involving explosive ordnance had been recorded across Syria, causing 2,325 casualties. For many Syrians living in rural areas, activities as routine as ploughing fields, tending livestock or harvesting crops can carry deadly risks. “For many rural Syrians, cultivating land, grazing animals and harvesting crops can be life-threatening,” he said. The FAO is working to identify areas where demining operations can deliver the greatest benefits for food production, rural livelihoods, safe returns of displaced people, water access and the revival of local markets. The conflict that erupted in Syria in 2011 killed more than half a million people, displaced millions and left large swathes of the country contaminated with explosive hazards. According to the United Nations, more than 14 million people remain exposed to risks from mines and unexploded ordnance. With Japanese funding, the FAO and the United Nations Mine Action Service are working alongside Syrian authorities to clear contaminated land and help revive agricultural production. However, Perri warned that funding for emergency agricultural assistance remains insufficient, leaving many rural families without critical seasonal support needed to restore farming activities. Through its 2026-2028 Emergency and Recovery Plan, the FAO aims to assist 9.8 million people across Syria and is seeking $286 million in funding. “We remain committed to supporting Syrian farmers, livestock breeders and rural communities so that agriculture can strengthen food security, restore livelihoods, encourage safe and dignified returns and help Syria move from emergency conditions toward sustainable recovery,” Perri said. Suggested By Editor Food insecurity spectre hovers over Syria as it faces worst drought in decades Suggested By Editor Food insecurity spectre hovers over Syria as it faces worst drought in decades
2026-06-24 13:23:04

Erdogan pushes new legal framework to accelerate PKK disbandment
Erdogan pushes new legal framework to accelerate PKK disbandment The move signals a potential breakthrough after a peace process between the Turkish state and the PKK came to a near standstill in recent months. Wednesday 24/06/2026 Turkish President Recep Tayyip Erdogan attends a news conference at the Presidential Palace in Ankara. ANKARA Turkish President Recep Tayyip Erdogan said on Wednesday that work was underway on a legal framework that would speed up the disbandment of the militant Kurdistan Workers Party (PKK) and that it would be put on parliament’s agenda without much delay. The move signals a potential breakthrough after a peace process between the Turkish state and the PKK came to a near standstill in recent months due to the Iran war and the concerns it triggered about further regional instability. The PKK, which waged a decades-long separatist insurgency against the Turkish state and is designated a terrorist group by Ankara and its Western allies, decided in May 2025 to disarm and disband, after an appeal from its jailed leader Abdullah Ocalan. Turkey announced last November its plans for establishing a new legal framework but the country’s Kurdish politicians had accused the government of moving too slowly. “At the point we have reached, we are working on a legal framework that will speed up the disbandment of the group. Once the necessary deliberations have been made, we will present the legislation in question to parliament without too much delay,” Erdogan told lawmakers from his ruling AK Party in parliament, without elaborating. “I believe we have the capacity to solve the issue without compromising on our state’s qualities, our people’s values,” he added, saying that the integration of Syrian Kurdish militants into Syria’s state apparatus, a key element of the process, was also moving along. The PKK launched its insurgency in 1984. It initially sought an independent Kurdish state in southeast Turkey but later changed its goals to autonomy and Kurdish political rights.
2026-06-24 13:19:44

HKeyBio Debuts HKEY-ExETM 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research BOSTON and SUZHOU, China , June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical contract research organization focused on autoimmune and allergic diseases, today announced the launch of HKEY-ExETM 1.0 , an EoE&EgE Evaluation Framework for eosinophilic esophagitis (EoE), eosinophilic gastroenteritis (EgE, also referred to as EGE), and related eosinophilic gastrointestinal disorders (EGIDs). HKEY-ExETM 1.0 is designed for drug developers working on type 2 inflammation, eosinophil recruitment, epithelial barrier dysfunction, tissue inflammation, and remodeling. The framework integrates disease modeling, in vivo efficacy evaluation, biomarker analysis, pathology assessment, mechanism-of-action studies, and cross-indication translational support. EoE Development Is Advancing, While Broader EGIDs Need More Interpretable Preclinical Tools EoE is a chronic, antigen-driven, immune-mediated disease of the esophagus, characterized by eosinophil infiltration, inflammation, epithelial barrier dysfunction, tissue injury, and remodeling. EgE and other non-esophageal EGIDs may involve the stomach, small intestine, colon, or multiple gastrointestinal tissue sites, creating complexity in model construction, histological evaluation, biomarker selection, and translational data interpretation. For candidates targeting IL-4/IL-13, IL-5, TSLP, Siglec-8, the CCR3/eotaxin axis, and other eosinophilic inflammation-related pathways, early preclinical studies need to clarify in vivo activity, tissue inflammation reduction, biomarker modulation, and cross-indication potential. HKeyBio Builds HKEY-ExETM 1.0 Around Four Core Modules 1. Disease Modeling for EoE and Related EGIDs HKeyBio supports preclinical study design and animal model development based on allergen-induced modeling strategies and immuno-inflammatory disease research experience. Protocols can be adapted by candidate mechanism, molecule type, target biology, development stage, and project objectives. For EoE studies, evaluation may focus on eosinophil infiltration, inflammatory cell recruitment, tissue injury, epithelial barrier changes, and fibrosis-related alterations. For EgE and other EGIDs, the framework may be extended to additional gastrointestinal tissue sites and disease-related molecular signals. 2. Multidimensional Efficacy Endpoint Evaluation Efficacy assessment in eosinophilic gastrointestinal diseases cannot rely on a single endpoint. HKEY-ExETM 1.0 combines histology, cytology, molecular biology, pathology, and biomarker analysis. Depending on study objectives, endpoints may include: Histopathological assessment of esophageal and gastrointestinal tissues; Quantitative analysis of eosinophil and inflammatory cell infiltration; Detection of inflammatory cytokines and chemokines; Evaluation of markers related to tissue injury, mucosal inflammation, and fibrosis; Assessment of candidate drug effects on inflammatory responses, tissue remodeling, and disease progression-related processes. 3. Type 2 and Eosinophilic Inflammation Biomarker Analysis HKeyBio has established biomarker detection and analysis capabilities for key inflammatory pathways, including IL-4, IL-5, IL-13, TSLP, eotaxin family chemokines, and other molecules related to eosinophil recruitment, activation, and tissue infiltration. These studies can help research teams evaluate expected pathway activity, inflammatory cascade modulation, and scientific rationale for later-stage development. 4. Cross-Indication Translational Research Support EoE, EgE, and other allergic inflammatory diseases share overlapping features, including type 2 inflammation, eosinophil recruitment, barrier dysfunction, and tissue remodeling. HKEY-ExETM 1.0 supports mechanism validation, model selection, endpoint design, and translational pathway assessment for multi-indication strategies. "EoE, EgE, and related EGIDs share important immuno-inflammatory characteristics, but they differ in affected tissue sites, pathological features, and endpoint evaluation requirements," said a representative of HKeyBio. "HKEY-ExETM 1.0 is designed to provide global drug developers with more systematic, interpretable, and mechanism-oriented preclinical research support." Looking ahead, HKeyBio will continue to strengthen disease model resources and translational research capabilities for EoE, EgE, and related EGIDs. About HKeyBio HKeyBio is a preclinical contract research organization focused on autoimmune and allergic diseases, providing in vivo pharmacology evaluation and translational research services from drug discovery through IND-enabling preparation. The company has established rodent and non-human primate preclinical platforms covering disease modeling, efficacy evaluation, mechanism-of-action studies, biomarker analysis, pathology testing, and translational medicine research. HKeyBio's core technical team has more than 20 years of autoimmune disease drug development experience and has supported more than 500 autoimmune disease-related IND research programs. For more information, please contact: Website: www.hkeybio.com Email: tech@hkeybio.com
2026-06-24 13:18:00

NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK , June 24, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Leaders talk future of marketing at Cannes Lions. Ashley Mastronardi delivers the pre-market update on June 24th The price of ICE Brent Crude Oil fell below $76 a barrel for the first time since late February. IBM (NYSE: IBM) led Global X NYSE 100 ETF gains Tuesday after a pair of analysts upgraded the company's 12-month price target on AI optimism. Abridge CEO Dr. Shiv Rao will join NYSE Live to discuss how its latest AI offering, and a pair of partnerships, will streamline care across the health sector. The NYSE and Beet.TV are delivering exclusive industry leader interviews at Cannes Lions, which can be seen on NYSE Live. Minute Media President Rich Routman reveals how its taking Sports Illustrated to new platforms. Kantar's Americas CEO Jeff Greenspoon explains how it helps brands and marketers deliver measurable results. Opening Bell Roads to Success celebrates 25 years of impact Closing Bell DT Midstream (NYSE: DTM) celebrates 5 years as a public company For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com U.S. Open champ Wyndham Clark at NYSE on June 23 Video - https://mma.prnasia.com/media2/2999816/NYSE_Content_Update_June_24.mp4
2026-06-24 13:18:00

Amir, Pakistani Prime Minister discuss bilateral relations and Ras Laffan incident developments

Doha, Qatar: The Amir HH Sheikh Tamim bin Hamad Al-Thani made a telephone call on Wednesday with the Prime Minister of the Islamic Republic of Pakistan HE Muhammad Shehbaz Sharif. 

At the outset of the call, HH the Amir expressed his sincere condolences and sympathy to HE the Pakistani Prime Minister over the victims of the explosion at an industrial facility in Ras Laffan, which resulted in the deaths and injuries of a number of Pakistani nationals, wishing the injured a speedy recovery.

For his part, HE the Pakistani Prime Minister expressed his deep gratitude and appreciation to HH the Amir for his heartfelt sentiments, praising the support and medical care provided by the State of Qatar to the injured as well as the efforts of the relevant authorities in responding to the incident.

Both sides expressed their solidarity with the families of the victims, affirming the two countries' firm commitment to ensuring the safety and well-being of their friendly peoples.

During the call, bilateral relations between the two countries were also discussed, in addition to developments in the region and the memorandum of understanding between the United States of America and the Islamic Republic of Iran. 

In this regard, the Pakistani Prime Minister praised the efforts of the State of Qatar in promoting regional security, peace and stability, expressing his appreciation for the efforts it is making in supporting security and stability in the region.


2026-06-24 13:17:21

Democratizing 3D-to-AI Production: Reallusion Debuts iClone Personal and Officially Launches AI Studio
SAN JOSE, Calif. , June 23, 2026 /PRNewswire/ -- Reallusion , the global leader in 3D animation software, today announced a major dual-release: the rollout of iClone Personal alongside the public launch of AI Studio . Featuring a massive upgrade in character consistency and identity precision, this release establishes a zero-barrier pipeline that bridges traditional 3D artistry and next-generation generative AI workflows. Reallusion releases iClone Personal, now permanently free for everyone, and integrates 3D-to-AI workflows with the official launch of AI Studio. Find out more about the 3D-to-AI directing workflow in this video . iClone Personal: Permanent 3D Creation and Freedom Replacing the traditional 30-day trial, iClone Personal offers artists, students, and freelancers a permanent, unrestricted environment to learn, direct, and animate 3D scenes indefinitely. By seamlessly integrating with the Reallusion ecosystem, allowing users to animate Character Creator actors and utilize ActorCore motion packs, while supporting full imports from other industry 3D tools, it serves as the perfect permanent environment for education and long-term pipeline compatibility testing. To provide ultimate flexibility, Reallusion now offers three distinct ways to use iClone: iClone Personal: A permanent, zero-cost tier for indefinite learning, scene blocking, and animation with full project access and entirely free rendering. While creation is unrestricted, it includes a limit of 30 exports for external 3D pipelines. Subscription Plans: A flexible, project-based option that completely lifts the 3D export limit. Ideal for creators who need to temporarily scale their pipeline and seamlessly export assets to game engines and external teams. If an active subscription ends, the software simply reverts to this Free version, keeping your work fully accessible. Perpetual License: The premier upgrade path for professional studios wanting full, permanent ownership of the software and completely unrestricted 3D asset export capabilities. iClone's standalone power will expand further with the upcoming RTX Render engine, launching in Open Beta in late July as a free update for iClone and Character Creator. This optimized engine delivers high-fidelity visuals directly within the software, allowing creators on any tier to complete entire animation projects without exporting to external 3D tools, making the core creation and rendering process completely free. AI Studio Official Launch: Enhanced Workflow for Next-Level Consistency Moving out of Early Access into full public availability, AI Studio continues to directly tackle the animation industry's biggest challenge of digital identity drift. While AI Actors were previously implemented during the Early Access phase to address these character consistency issues, this official launch takes that established foundation to the next level. The re-engineered workflow locks down absolute identity precision from any angle or style, virtually eliminating visual drift even during drastic shot changes through two primary enhancements: Enhanced Video Integration: AI Actors can now be combined as a reference layer directly inside the Seedance 2.0 video pipeline to ensure it remains flawlessly stable from the first frame to the last. Image Edit Deployment: These hyper-consistent AI Actors can be deployed directly within the Image Edit pipeline across multiple angles. This allows creators to seamlessly combine, modify, or swap AI Actors with other assets for complex, derivative storytelling workflows without losing character integrity. Unlocking the Full Creative Potential of Seedance 2.0 As a platform that integrates multiple premier generative models, including Kling 3.0, Veo 3, Nano banana, Flux, and others, Reallusion is constantly pushing the boundaries to let users harness the full creative power of these technologies. By introducing native support for what the industry knows as Elements in Seedance, the platform unlocks unprecedented artistic control. Users can now seamlessly mix, match, and combine multiple reference inputs, including Image, Video, Audio, and AI Actors, alongside native 3D scene data. Instead of guessing with unpredictable text prompts, creators can orchestrate complex camera movements and character choreography in a true 3D environment, allowing the AI to flawlessly execute the final cinematic look with complete structural precision. Flexible AI Cloud Plans Open to Everyone To support the computing power required for heavy AI generation, Reallusion has opened its tiered AI Cloud Plans (Starter, Standard, and Pro) to the public. Subscriptions unlock premier generation models like Seedance 2.0, Kling 3.0, and Veo 3, alongside an expansive library of over 5,000 premium 3D assets, including poses, posed people, interior furnishings, buildings, animals, trees, plants, and vehicles, and 200+ production-ready AI actors. Additionally, the included AI Points serve as a unified currency that expands beyond video generation to power other Reallusion cloud services. This includes Video Mocap for extracting precise AI motion capture from any video clip, and the advanced Headshot 3 image workflow. Availability Get iClone Personal: New users can download the software for free from the official iClone Product Page to begin building, directing, and animating 3D scenes without time constraints. Unlock iClone Pipeline Export (Subscription or Perpetual): Upgrade to a flexible subscription plan or a perpetual license to permanently remove the 30-time export limit. This fully unlocks iClone's pipeline connectivity, enabling seamless 3D project and asset exports directly to game engines and other external 3D applications. Access AI Studio: Now fully open to the public, existing users can update their software via the Reallusion Hub to access the fully integrated AI Studio toolkit. Free-tier users and trial explorers can begin testing the pipeline instantly, with 500 free AI Points automatically provided upon installation. Explore AI Cloud Plans: To tap into premier generative models like Seedance 2.0, Kling 3.0, and Veo 3, along with the expanded premium asset library, creators can review options and subscribe directly on the AI Cloud Plans Page .
2026-06-23 11:54:00

New date for CNN's Global Perspectives: In Doha, taking place on October 29

Doha, Qatar: CNN’s flagship events series Global Perspectives will take place in Doha on October 29, convening dignitaries, political and business leaders and visionaries for important conversations on geopolitics, technology, media and culture. 

Global Perspectives: In Doha marks the first time that CNN will hold its flagship events series in the Middle East and Gulf region. The event will take place at the Rosewood Doha, with Media City Qatar as Host Partner, building on an established relationship following CNN’s decision to launch a new operation in Qatar last year as part of the network’s broader global and regional content strategy. The new date for Global Perspectives: In Doha was agreed following a meeting between CNN Worldwide Chairman & CEO Sir Mark Thompson and His Excellency Sheikh Abdulla bin Ali Al Thani, Chairman of Media City Qatar.

At October’s event, CNN journalists including Christiane Amanpour, Richard Quest, Becky Anderson and Eleni Giokos will lead conversations with leaders from the region and beyond, examining how regions such as the Gulf are shaping the world’s next chapter of economic power, technological innovation and cultural influence. Editorial content and news-making interviews from the event will run across CNN platforms. 

Following the success of the inaugural Global Perspectives: On Africa summit and an impactful program at the World Economic Forum in Davos, the Global Perspectives series continues to travel the world to explore the big ideas, bold leadership and dynamic economies at the frontlines of global transformation. CNN will host two full editions of its flagship event series this fall with Global Perspectives: In Doha as well as Global Perspectives: In Bangkok. Global Perspectives: In Doha had been originally scheduled for April 20 but was postponed due to events in the region.  

Global Perspectives: In Doha marks another milestone in the growing collaboration between CNN and Media City Qatar. Since establishing its operation in Doha in 2025, CNN has expanded its presence through initiatives including CNN Creators, ongoing talent development initiatives, and now the region's first edition of Global Perspectives.

Global Perspectives also provides opportunities for commercial partners to reach and engage with those attending Global Perspectives, as well as CNN audiences across the world. In addition to branding and activation at the event for official Host Partner Media City Qatar, Dangote is the first additional sponsor announced for Global Perspectives: In Doha, with branding at the event, and advertising alignment with Global Perspectives content on CNN platforms.


2026-06-23 11:53:49

Τι κάνεις;

0.024946928024292


Νέα
Νέα
Κατάρ
Τελευταίες ειδήσεις και τίτλοι
Κατάρ
Νέα